Health & Fitness
Health and Fitness
Health and Fitness
Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011 Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston
Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference... -- NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ --
Cumberland Pharmaceuticals to Present at the 2011 Wells Fargo Securities Healthcare Conference in Boston
NASHVILLE, Tenn., June 7, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Wells Fargo Securities Healthcare Conference in Boston at 2:30 p.m. Eastern Time on Wednesday, June 22, 2011.
The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section on Cumberland Pharmaceuticals' website at [ www.cumberlandpharma.com ].
Shortly following the live webcast a replay will also be available on the Company website.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients.
For more information on Cumberland Pharmaceuticals, please visit the Company website at [ www.cumberlandpharma.com ].
SOURCE Cumberland Pharmaceuticals Inc.
[ Back to top ] RELATED LINKS
[ http://www.cumberlandpharma.com ]
